Literature DB >> 15831712

Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes.

Margaret L Shumate1, Gladys Yumet, Tamer A Ahmed, Robert N Cooney.   

Abstract

Sepsis results in hepatic "growth hormone (GH) resistance" with reductions in plasma IGF-I despite a two- to fourfold increase in circulating GH. In this study, we examine the effects of IL-1 on GH receptor (GHR) expression, GH signaling (via the JAK/STAT and MAPK pathways), and the induction of gene expression [IGF-I mRNA and serine protease inhibitor (Spi) 2.1] by GH in CWSV-1 hepatocytes. Incubation of cells with IL-1beta (10 ng/ml, 24 h) had no effect on the relative abundance of GHR or signaling proteins JAK2, STAT5b, and ERK1/2 in cell lysates. Baseline phosphorylation of GHR, JAK2, STAT5b, and ERK1/2 was minimal. After GH stimulation, tyrosine phosphorylation of GHR, JAK2, STAT5b, and ERK1/2 increased 2- to 10-fold. However, neither the time course nor the magnitude of GHR, JAK2, and ERK1/2 phosphorylation by GH were significantly altered by IL-1. The GH-induced translocation of STAT5b to the nucleus was not prevented by IL-1. Although phosphorylated STAT5 in nuclear extracts from GH + IL-1 cells was decreased by 24% (vs. controls) 15 min after GH stimulation, this did not result in reduced STAT5-DNA binding activity. Pretreatment with IL-1 did not significantly decrease IGF-I mRNA stability. We conclude that IL-1 only minimally affects the time course of JAK2/STAT5 and MAPK signaling by GH. Therefore, an inhibitory effect of IL-1 on IGF-I and Spi 2.1 mRNA synthesis by GH represents the most likely mechanism for IL-1-mediated GH resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831712     DOI: 10.1152/ajpgi.00424.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA).

Authors:  Suvimol Chirathivat Hill; Madjimbaye Namde; Andrew Dwyer; Andrew Poznanski; Scott Canna; Raphaela Goldbach-Mansky
Journal:  Pediatr Radiol       Date:  2006-11-28

2.  Altered time structure of neuro-endocrine-immune system function in lung cancer patients.

Authors:  Gianluigi Mazzoccoli; Gianluigi Vendemiale; Angelo De Cata; Stefano Carughi; Roberto Tarquini
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

3.  Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse.

Authors:  Chidozie J Amuzie; Junko Shinozuka; James J Pestka
Journal:  Toxicol Sci       Date:  2009-07-22       Impact factor: 4.849

Review 4.  Mechanisms of growth impairment in pediatric Crohn's disease.

Authors:  Thomas D Walters; Anne M Griffiths
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

5.  Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β.

Authors:  Yueshui Zhao; Xiaoqiu Xiao; Stuart J Frank; Herbert Y Lin; Yin Xia
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-03       Impact factor: 4.310

6.  Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis.

Authors:  Jamie L Bessich; Amanda B Nymon; Lisa A Moulton; Dana Dorman; Alix Ashare
Journal:  J Immunol       Date:  2013-05-22       Impact factor: 5.422

7.  Nuclear factor-kappaB mediates the inhibitory effects of tumor necrosis factor-alpha on growth hormone-inducible gene expression in liver.

Authors:  Mark D Buzzelli; Murali Nagarajan; John F Radtka; Margaret L Shumate; Maithili Navaratnarajah; Charles H Lang; Robert N Cooney
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

8.  Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation.

Authors:  Chidozie J Amuzie; James J Pestka
Journal:  Toxicol Sci       Date:  2009-10-04       Impact factor: 4.849

Review 9.  Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.

Authors:  Christoffer Soendergaard; Jonathan A Young; John J Kopchick
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

10.  Physiological changes of growth hormone during lactation in pup rats artificially reared.

Authors:  Cesar G Toriz; Angel I Melo; Carmen Solano-Agama; Edgar Giovanhi Gómez-Domínguez; Ma de Los Angeles Martínez-Muñoz; Jorge Castañeda-Obeso; Eunice Vera-Aguilar; Elsa Liliana Aguirre-Benítez; Lucero Romero-Aguilar; Margarita González-Del Pliego; Ismael Jiménez-Estrada; Maricela Luna; Juan Pablo Pardo; Javier Camacho; Maria Eugenia Mendoza-Garrido
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.